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The Human Cytomegalovirus (HCMV) UL72 gene is considered to be the equivalent of the dUTPase gene of the Alpha- and Gamma-
herpesviruses. To characterize its function, the expression profiles of UL72 at both the RNA and the protein level were determined. The gene
is expressed with a late kinetics and the corresponding UL72 46-kDa protein accumulates late during infection in the cytoplasm of infected
cells. The pUL72 was expressed in E. coli and the purified recombinant protein did not display a detectable dUTPase activity. The viral yields
of reconstituted HCMV RVDUL72 viruses carrying a deletion within the UL72 ORF demonstrated a moderate growth defect following low
MOI infections, whereas their DNA synthesis profiles were not significantly different from those of the parental HCMV RVAD169. These
results demonstrate that the UL72 gene product is not a dUTPase and is not essential for replication in human fibroblasts.
D 2004 Elsevier Inc. All rights reserved.Keywords: Human cytomegalovirus; dUTPase; UL72 gene; Deletion mutant viruses
Introduction cells and tissues, including differentiated, post-mitotic cells,Human Cytomegalovirus (HCMV) is a ubiquitous beta-
herpesvirus that generally causes benign or asymptomatic
infections. However, it is the leading viral cause of congen-
ital infection in humans and a primary cause of morbidity in
immunocompromised hosts, such as transplant recipients
and HIV-infected patients at risk for life-threatening dis-
eases (Fortunato and Spector, 1999; Griffith, 2000; Land-
olfo et al., 2003; Mocarski and Courcelle, 2001). Moreover,
HCMV infection has been linked to chronic vascular dis-
eases, including transplant vasculopathy, restenosis, and
atherosclerosis (Jarvis and Nelson, 2002). The pathogenesis
of HCMV-associated diseases largely depends on the ability
of the virus to establish latent lifelong infection, counteract
host defense mechanisms, and replicate in a wide variety of0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: giorgio.gribaudo@unito.it (G. Gribaudo).such as mesenchymal cells, endothelial cells, epithelial cells,
smooth muscle cells, and monocytes/macrophages (Bis-
singer et al., 2002; Hengel et al., 1998; Lalani et al.,
2000; Sinzger et al., 1995). Lysis of permissive infected
cells as well as altered cellular gene expression occurring
independently of virus replication are thought to contribute
to HCMV-mediated pathogenesis (Pass, 2001). Studies from
many laboratories have indeed revealed that the reprog-
rammed gene expression of the HCMV-infected cell is
associated with stimulation of genes involved in the gener-
ation of pro-inflammatory responses, such as cytokines,
chemokines, adhesion molecules, extracellular matrix pro-
teins, and inflammatory mediators (Browne et al., 2001;
Fortunato et al., 2000; Simmen et al., 2001). Among the
cellular genes whose expression is regulated by HCMV
infection, those coding the enzymes of the synthesis of
DNA precursors play an important role in virus replication.
The absence of functional virus-encoded dNTPs-synthesiz-
ing enzymes such as thymidine kinase (TK), dihydrofolate
reductase (DHFR), thymidylate synthase (TS), and ribonu-
P. Caposio et al. / Virology 325 (2004) 264–276 265cleotide reductase (RR) (Chee et al., 1990; Davison et al.,
2003; Rigoutsos et al., 2003), in fact, compels HCMV to
depend on host cell metabolism to ensure an appro-
priate supply of dNTPs for its DNA replication. How-
ever, these host enzymes are expressed at very low levels
in post-mitotic cells. To explain this apparent paradox, it has
been hypothesized that HCMV infection of quiescent cells
induces biochemical pathways that are required for DNA
replication, including enzymes involved in nucleotide me-
tabolism. Subsequently, to gain selective access to the newly
synthesized dNTPs, the virus prevents replication of the host
cell DNA by blocking cell cycle progression at the begin-
ning of S phase (Fortunato et al., 2000; Wiebusch and
Hagemeier, 2001). We have indeed demonstrated that this
occurs for some of the enzymes involved in the thymidylate
biosynthesis. Infection of quiescent fibroblasts with both
murine and human CMV, in fact, increases cellular DHFR
and TS content, and inhibition of these activities abrogates
virus replication (Gribaudo et al., 2000, 2002; Lembo et al.,
1998, 1999). TS catalyzes the de novo biosynthesis of
thymidylic acid (dTMP) by reductive transfer of the meth-
ylene group from 5,10-methylene-tetrahydrofolate to the 5
position of the substrate, deoxyuridylic acid (dUMP), to
form dTMP and dihydrofolate (Maley and Maley, 1990).
Therefore, the intracellular availability of dUMP may be the
rate-limiting step in dTMP biosynthesis and hence critical
for efficient CMV replication in quiescent cells. In mam-
malian tissues, dUMP may be produced by the deaminationFig. 1. Characteristics of UL72 RNA expression. (A) Schematic representation
Expression of UL72 mRNA in HCMV-infected HELF cells. Subconfluent HELF
HCMVAD169 (MOI of 5 PFU/cell) or mock-infected (lane 1). Total RNA (30 Ag/s
72 h (lane 6) p.i. was analyzed by Northern blotting. The filter was hybridized with
as described in Materials and methods. The positions of 28 and 18 S rRNA are iof deoxycytidine 5V-monophosphate nucleotide (dCMP)
catalyzed by deoxycytidylate aminohydrolase (dCMP de-
aminase). Alternatively, dUMP generation may involve the
reduction of UDP to dUDP by ribonucleotide reductase,
followed by phosphorylation of dUDP to dUTP and finally
hydrolysis of dUTP to dUMP and pyrophosphate by deox-
yuridine triphosphate pyrophosphatase (dUTPase) (Maley
and Maley, 1990; McIntosh and Haynes, 1997). More
recently, we have observed an increase of dCMP deaminase
level, whereas that of dUTPase was undetectable in HCMV-
infected fibroblasts (Gribaudo et al., 2003). This differential
regulation of the two main dUMP-providing enzymes sug-
gests that dCMP deaminase may be the major contributor of
the TS substrate for de novo TTP synthesis. However, the
lack of a significant stimulation of cellular dUTPase raises
the question of whether this enzymatic activity is required
for HCMV replication at all, because in addition to its role
in supplying dUMP, it plays a critical role in the mainte-
nance of uracil-free DNA by reducing the availability of
dUTP as a substrate for DNA replication. Occurrence of
UL72 gene within the HCMV genome, regarded as the
evolutionary counterpart of the dUTPase gene in other
herpesvirus (Chee et al., 1990; McGeoch and Davison,
1999), suggests that it may compensate for the nonstimula-
tion of the cellular enzyme. These results prompted us to
determine whether: (i) UL72 is expressed during HCMV
replication; (ii) encodes a functional enzyme, and (iii) is
essential during in vitro HCMV replication.of the HCMV AD169 UL72–75 region showing the UL72 location. (B)
cells were growth-arrested in low-serum medium and then infected with
ample) isolated at 12 h (lane 2), 24 h (lane 3), 36 h (lane 4), 48 h (lane 5), or
a radiolabeled single-stranded antisense RNA probe corresponding to UL72
ndicated.
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gene and protein expression and the lack of an apparent
dUTPase activity on the part of the recombinant protein.
Furthermore, mutant viruses lacking the UL72 ORF display
plaque size and morphology, and viral yield in infected
human fibroblasts comparable with those of the parental
strain, indicating that the UL72 gene product is not essential
for replication in these cells.Fig. 2. Characteristics of pUL72 expression. HELF cells were growth-
arrested in low-serum medium and then infected with HCMVAD169 (MOI
of 5 PFU/cell) or mock-infected. Total cell extracts were prepared at the
indicated times after infection, fractionated by SDS-PAGE (50 Ag protein/
lane), and analyzed by immunoblotting with the anti-UL72 antibodies, with
the anti-IEA mAb, the anti-UL44 mAb, or the anti-UL99 mAb described in
Materials and methods. Actin immunodetection with a mAb was performed
as an internal control. Cell extracts were isolated from mock-infected cells,
cells infected with HCMV for 24, 48, 72, and 96 h, or cells infected with
HCMV and treated with PFA for 48 and 72 h.Results
Characterization of UL72 gene expression
The reading frame 72 (termed UL72, nt 105721–
104555 of the AD169 nucleotide sequence, accession no.
X17403.1) (Fig. 1A) in the unique long arm of the HCMV
genome codes for a putative protein of 388 amino acids
(aa) with a theoretical molecular mass of about 43.5 kDa.
To study the characteristics of its expression, UL72 was
amplified by PCR from AD169 DNA and cloned. Se-
quence analysis revealed a perfect match with the previ-
ously reported sequence (Chee et al., 1990). To analyze
transcripts originating from the UL72 ORF, total RNA
from HELF cells infected with HCMVAD169 was isolated
at different times postinfection and was analyzed by
Northern blots using a UL72 antisense RNA as a probe.
A major signal corresponding to an RNA size of about 3.5
kb was only detected in samples obtained at 36, 48, and 72
h p.i. (Fig. 1B), demonstrating that the UL72 RNA was not
transcribed abundantly until late times of infection. The
signal increased during this time frame and an additional
signal corresponding to a 2.1-kb RNA only became
detectable at 72 h p.i. These results indicate that UL72
is expressed with a kinetics of a late viral gene. Northern
analysis of UL72 transcripts following treatment of
infected cells with PFA was consistent with its classifica-
tion as a true late gene, since PFA abolished the expression
of the 3.5 and 2.1 kb RNA signals at 72 h p.i. (data not
shown).
To characterize the protein product of ORF UL72,
polyclonal rabbit antibodies were raised against a bacterial
GST fusion protein containing the UL72 segment from aa
61 to 388. These antibodies were then used to probe
immunoblots of total HELF cell protein lysates prepared
at different times p.i. A single protein of an apparent
molecular mass of about 46 kDa was detected with the
antiserum starting from 48 h p.i. (Fig. 2, UL72 panel) and
this signal increased considerably until 96 h p.i. pUL72 was
not detected in mock-infected cells (Fig. 2, UL72 panel),
nor by pre-immune serum (data not shown). Its predicted
size (43.5 kDa) corresponds to the band detected by the
anti-UL72 antibodies. To further confirm the temporal
kinetic class of UL72 expression, HCMV-infected HELF
cells were grown in the continuous presence of PFA and
protein extracts were prepared at 48 and 72 h p.i. Here,pUL72 was not detected at 48 h nor at 72 h, confirming that
it is expressed with a late gene kinetics (Fig. 2, UL72
panel). Expression of IEA (IE1 and IE2), UL44 and UL99
was assessed as a control for IE, E, and L HCMV proteins
(Fig. 2).
The intracellular location of pUL72 was then investigated
by confocal laser immunofluorescence microscopy using the
anti-UL72 and the anti-IEA mAb as probes. Mock-infected
cells displayed only background fluorescence, whereas nu-
clei of infected cells were stained by the anti-IEA mAb
throughout infection. In infected cells, pUL72 stained from
48 h p.i. throughout infection and showed a diffuse cytoplas-
mic staining pattern (Fig. 3). A similar pattern was also
observed in HELF cells transiently transfected with a
pUL72 expression vector (Fig. 3, right bottom panel).
Fig. 3. Localization of UL72 protein in HCMV-infected HELF cells by indirect immunofluorescence. HELF cells grown on coverslips were either transiently
transfected with the eukaryotic expression plasmid pcDNA3-UL72 or infected with either HCMVAD169 (MOI of 0.2 PFU/cells) or mock-infected. At 24, 48, 72,
96 h p.i., or 24 h post transfection, cells were washed with PBS, fixed with acetone/methanol, and permeabilized. Infected cells were costained with rabbit anti-
UL72 antibodies (green fluorescence) and mouse anti-HCMV IEAmAb (red fluorescence), whereas transfected cells were stained with anti-UL72 antibodies and
propidium iodide as described in Materials and methods. The immunolocalization experiments were repeated twice and representative results are presented.
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UL72 of HCMV is regarded as the evolutionary counter-
part of the dUTPase gene in other herpesviruses, though its
deduced aa sequence lacks some of the conserved dUTPase
canonical sequence motifs (McGeoch and Davison, 1999).
To determine whether the UL72 protein is functionally active,
the UL72-corresponding ORF (1–388) was inserted into
pGEX4T3 and expressed as a GST-fusion protein in E. coli
as described for other herpesvirus dUTPases (Kremmer et al.,
1999). The apparent molecular mass of the fusion protein was
72 kDa, as predicted when fusing the 26-kDa GST to the 46-
kDa pUL72 protein (Fig. 4A, lane 4). The fusion protein was
bound to immobilized glutathione, and after removal of the
nonspecifically boundmaterial, pUL72was released from the
GST moiety by thrombin cleavage. The released protein had
an apparent molecular weight of about 46 kDa (Fig. 4A, lane
5) identical to that identified by anti-pUL72 antibodies in
extracts from HCMV-infected HELF cells (Fig. 2). Analysis
on an SDS-PAGE gel demonstrates purity >90% (Fig. 4A).
As a control for expression, purification and thrombin release
procedures, the human N-dUTPase coding gene (the 22-kDa
nuclear form) (Ladner et al., 1996) was cloned and produced
as a recombinant protein (Fig. 4A, lanes 2 and 3), respective-
ly). The synthesized pUL72 was then tested for dUTPase
activity by incubation with 3H-labeled dUTP and subsequent
TLC. As shown in Fig. 4B, 0.5 or 2 Ag of purified pUL72
failed to hydrolyze dUTP to dUMP at a rate significantly
higher than that of the nonrelated GST protein. By contrast,
the same amounts of recombinant human N-dUTPase pro-duced, as expected, a total conversion of the input dUTP to
dUMP (Fig. 4B). Moreover, the Murine Herpesvirus 68
ORF54 (the dUTPase gene of MHV68) was expressed and
purified using the very same procedure and the recombinant
protein shown to be an active dUTPase (Caposio et al.,
unpublished data). This result demonstrates the reliability
of our experimental procedures to produce recombinant
herpesvirus dUTPases. The results obtained with the recom-
binant UL72 protein and those demonstrating the lack of
significant dUTPase activity in crude cell extracts or in
immunoprecipitates prepared from HCMV-infected quies-
cent HELF cells (data not shown) suggest that the product
of the HCMVAD169 UL72 gene is not an active dUTPase.
Comparison of the UL72 sequence from different HCMV
isolates
The AD169 strain may have undergone significant genetic
modifications due to the selection pressure imposed by
multiple passages on human fibroblasts causing both aa
sequence variation and loss of several genes present in
wild-type isolates (Cha et al., 1996). Therefore, it was of
interest to evaluate the nucleotide and deduced aa sequences
of UL72 fromwild-type clinical isolates and compare them to
the AD169 strain. The entire UL72 ORF from two clinical
isolates and the low-passage TB40/E isolate was therefore
amplified by PCR and sequenced to determine the extent of
sequence variability. The alignment of the four UL72 aa
sequences compiled with the Clustal X (1.8) multiple se-
quence alignment program (Fig. 5) indicates that the UL72
Fig. 4. dUTPase assay of recombinant UL72 and humanNdUTPase proteins.
The recombinant UL72 protein was expressed in E. coli as a GST-UL72
fusion protein, immobilized on a glutathione-sepharose beads and released
by thrombin digestion. Purified GST-UL72 and thrombin-released UL72
were then assayed for dUTPase activity as described in Materials and
methods. The human nuclear dUTPase isoform (NdUTPase) was expressed
and purified as described for UL72. (A) SDS-PAGE pattern of purified
recombinant NdUTPase and UL72 proteins. Molecular weight markers (lane
1), pGST-NdUTPase (lane 2), pNdUTPase (lane 3), pGST-UL72 (lane 4),
pUL72 (lane 5). (B) dUTPase enzyme assay. The assay was performed as
described in Materials and methods with 0.5 (empty bars) and 2 Ag (filled
bars) of the recombinant proteins. The assay was repeated three times and
representative results are shown.
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strains and therefore suggests that the UL72 function(s) have
to be maintained for virus growth or virus structure in vivo. In
addition, the few substitutions were mapped outside the
putative dUTPase sequence motifs (1–5) conserved in alpha
and gamma-herpesviruses expressing functional enzymes
(McGeehan et al., 2001; McGeoch, 1990).
Construction and characterization of mutant viruses lacking
the UL72 coding sequence
To investigate the pUL72 role(s) during HCMV infection,
we generated substitution mutant viruses carrying a marker
gene in the place of the UL72 ORF (Borst et al., 1999).
Deletion of UL72 was achieved by linear recombination with
a PCR fragment in E. coli (DH10B) containing AD169-BACand expressing E recombination functions (redahg). The
PCR fragment was generated using the kanamycin resistance
gene and primers containing HCMV-homologous sequences.
Structural analysis of two AD169DUL72-BAC selected
clones (nos. 2 and 3) was performed by restriction map-
ping and Southern blot hybridization for the presence of
the kanamycin resistance cassette. Reconstitution of
RVAD169DUL72 was obtained by transfection of DUL72-
BAC into human fibroblasts. Fig. 6 (upper panel) reports the
profiles of the AD169-BAC and the clone 3 DUL72-BAC
DNA bacmid (A + B) and reconstituted virus (C + D). As
predicted (Fig. 6, upper panel, A + B), in the HindIII digest,
kanR insertion cleaves a 22.8-kb band (A + B, lane 3) in
AD169-BAC to a 20.4-kb and a 2.4-kb fragment in DUL72-
BAC clones (A + B, lanes 1–2), respectively. In the EcoRI
digest, kanR insertion shifts a 16.4-kb fragment (A, lane 6) in
AD169-BAC to a 17.6-kb fragment (A, lanes 4–5) in
DUL72-BAC clones. Southern blot analysis (Fig. 6, upper
panel B + D) confirmed the presence of kanamyicin resis-
tance sequences in the DUL72 clone 3 bacmid and recon-
stituted virus. A similar pattern was obtained for the DUL72
clone 2 bacmid and reconstituted virus (data not shown). To
ascertain whether the site-directed mutagenesis of the UL72
sequences resulted in the loss of pUL72 expression, prolif-
erating HELF cells were infected with reconstituted viruses
and protein extracts analyzed for pUL72 expression by
immunoblotting. As shown in Fig. 6 (lower panel), pUL72
was absent from RVDUL72 clones 2 and 3 (lanes 3–4),
whereas, as expected, it was produced by RVAD169 (lane 2).
The UL72 protein is dispensable for in vitro growth
To determine if deletion of UL72 had an effect on viral
replication, we compared the viral yield and viral DNA
content of RVAD169 and two independent RVDUL72 viruses
(clones 2 and 3) in multistep growth curves in both quiescent
and exponentially growing HELF cells infected at different
multiplicity. Fig. 7A shows the viral yields obtained at 1–4,
6, 8, 10, and 12 days p.i. from quiescent (left panels) or
growing (right panels) cells infected at MOIs of 0.1 or 1.
While a moderate growth defect (2-fold reduction) was
observed for RVDUL72 mutant viruses at a MOI of 0.1, no
significant impairment was measured at a MOI of 1. Addi-
tionally, no obvious differences in plaque size and morphol-
ogy were detected. Evaluation of viral DNA kinetic synthesis
in cells infected with RVAD169 or RVDUL72 mutant viruses
did not reveal significant differences (Fig. 7B). Hence,
mutations of the UL72 ORF slightly affect virus replication
in vitro, indicating that it is not essential for HCMV growth in
human fibroblasts.Discussion
Since the release of the complete DNA sequence of the
AD169 strain (Chee et al., 1990) and its reanalysis (Davison
Fig. 5. Alignment of UL72 amino acid sequences from different HCMV strains. The nucleotide sequence of the UL72 gene was determined in two clinical
isolate HCMV strains (VR5438, VR6264) and in the endothelial cell tropic TB40/E strain. Their UL72 deduced aa sequences were compared using that of the
AD169 laboratory-adapted strain as the arbitrary reference. The substitutions are highlighted. The HSV-1 UL50 aa sequence (GenBank P10234) (McGeoch
et al., 1988) is shown as the prototype of functional herpesvirus dUTPase and the five standard conserved motifs (1–5) important for enzymatic activity are
shown. Motif 6 is a specific element conserved in the alpha- and betaherpesvirus dUTPases (McGeehan et al., 2001). The sequences were aligned using the
Clustal X (1.8) multiple sequence alignment program http://www.ebi.ac.uk).
P. Caposio et al. / Virology 325 (2004) 264–276 269et al., 2003), the UL72 gene has been considered, from
sequence similarities, as the HCMV homolog of the dUT-
Pase genes of Alpha- and Gammaherpesvirinae. Multiple
alignments of cellular and viral dUTPase sequences indicate
that despite the variation in the copy number of the
characteristic motifs, which are duplicated in the herpesviral
dUTPases, most active dUTPases share a common arrange-
ment of five conserved aa motifs (Baldo and McClure,
1999; McClure, 2001; McGeehan et al., 2001; McGeoch,
1990; McIntosh and Haynes, 1997; McIntosh et al., 1992;
Mol et al., 1996). Lack of conservation of most of the five
motifs in the UL72-deduced sequence (Fig. 5) has led to the
suggestion that this protein does not possess a true dUTPaseenzymatic activity, though no experimental evidence has
been provided. To definitively test this long-standing hy-
pothesis, we have cloned UL72 from the AD169 genome to
start its functional characterization. Here, we demonstrate
that the UL72 protein product does not elicit any detectable
dUTPase activity in our experimental conditions. Although
the coding capacity of UL72 is similar to that of alpha and
gamma herpesvirus dUTPase genes, the absence of conser-
vation of the five amino acid motifs supports the absence of
a dUTPase activity. The present UL72 ORF may thus have
arisen due to extensive mutation from an ancestral herpes-
viral active dUTPase (McGeehan et al., 2001). The lack of
UL72 involvement in nucleotide biosynthesis could be
Fig. 6. Characterization of the RVAD169DUL72 mutant viruses. (Upper panel) Structural analysis of the AD169DUL72-BACs and of RVAD169DUL72
reconstituted viruses. DNA from two independently generated clones of AD169DUL72-BAC (A + B; lanes 1–2, 4–5) and AD169 reference BAC (A + B;
lanes 3, 6) was digested with HindIII (lanes 1–3) or EcoRI (lanes 4–6) and separated on a 0.5 agarose gel, blotted and probed with pACYC to visualize kanR
insertion (B, lanes 1–6). As predicted (A + B), in the HindIII digest, kanR insertion cleaves a 22.8-kb band (A + B, lane 3) in AD169-BAC to a 20.4-kb and a
2.4-kb fragment (A + B, lanes 1–2) in DUL72-BAC, respectively. In the EcoRI digest, kanR insertion shifts a 16.4-kb fragment (A, lane 6) in AD169-BAC to a
17.6-kb fragment (A, lanes 4–5) in DUL72-BAC. DNA of the reconstituted virus RVAD169DUL72 (clone 3) (C + D) was digested with either HindIII (lane 2)
or EcoRI (lane 1) electrophoresed on an 0.5% agarose gel (C) and hybridized with kanamycin resistance gene (D). M, 1-kb molecular size marker. (Lower
panel) Lack of pUL72 expression in reconstituted RVDUL72 viruses. Proliferating HELF cells were infected with HCMVAD169 (lane 1), RVAD169 (lane 2),
RVDUL72-2 (clone 2) (lane 3), RVDUL72-3 (clone 3) (lane 4) (MOI of 5 PFU/cell). Total cell extracts were prepared at 72 h p.i., fractionated by SDS-PAGE
(50 Ag protein/lane), and analyzed by immunoblotting with the anti-UL72 antibodies or with the anti-IEA mAb as described in Materials and methods. As an
additional control for UL72 expression, extracts from HELF cells transiently transfected with the pcDNA3-UL72 vector were also included (lane 5).
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compared to alpha- and gamma herpesviruses in supplying
deoxyribonucleotide to the viral DNA polymerase. Alpha
and gamma herpesviruses, in fact, encode functional deoxy-
ribonucleotide-synthesizing enzymes, such as ribonucleo-
tide reductase, thymidine kinase, thymidylate synthase, and
dUTPase. Viral dUTPases control dUTP concentrations and
provide dUMP as precursor for the TTP biosynthesis
pathway (McGeehan et al., 2001; Studebaker et al., 2001).
It has been suggested that viral dUTPases facilitate virus
replication in differentiated nondividing cells that lack
expression of the endogenous cell cycle-regulated enzyme,
whereas they are nonessential in dividing tissues (McClure,
2001; McGeehan et al., 2001). Absence of UL72’s dUTPase
activity raises the question of the requirement of thisenzymatic activity for HCMV replication in nondividing
cells because cellular and viral dUTPases play a critical role
in the maintenance of uracil-free DNA by reducing the
availability of dUTP as a substrate for DNA replication. It
has been reported that the functional uracil-DNA glycosy-
lase (UNG) encoded by the HCMV UL114 gene is required
for efficient viral DNA replication in quiescent cells, where
in the absence of viral or cellular UNG expression DUNG-
mutant viruses failed to proceed to late-phase DNA repli-
cation (Courcelle et al., 2001; Prichard et al., 1996). These
findings have suggested that by removing uracil residues
incorporated early during viral DNA replication, viral UNG
introduces nicks serving as substrates for initiation of
recombination-dependent replication late in infection. Mis-
incorporation of dUTP and subsequent excision by viral
Fig. 7. Multiple-step growth curve analysis. (A) Growth curves of BAC-reconstituted RVAD169 and RVAD169DUL72 (designated RVDUL72) viruses in
HELF cultures. Titers were measured at 1–4, 6, 8, 10, and 12 days p.i. by standard plaque assay on HELF cells. Growth curves were determined in both
quiescent or proliferating HELF cells infected (MOI of 0.1 or 1 PFU/cell). (B) Viral DNA synthesis of reconstituted RVAD169 and RVDUL72 viruses. The
DNA synthesis rates of RVAD169 and RVDUL72 viruses were determined during their replication in quiescent or proliferating HELF cells infected (MOI of
0.1 PFU/cell). Total genomic DNAwas isolated from infected cells at 1–4, 6, 8, and 10 days p.i. and immobilized on a hybridization membrane by a dot blot
apparatus. The filters were sequentially hybridized with 32P-labeled HCMV IE1 and G3PDH probes. The hybridization signals were quantitated with a
phosphoimager and adjusted to the differences in G3PDH gene levels.
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cells) is therefore though to facilitate the transition from
early-phase replication (origin-dependent with a bidirectio-
nal theta mechanism) to late-phase amplification (with a
rolling-circle form of DNA replication) (Chen et al., 2002;
Courcelle et al., 2001). The lack of any HCMV-encoded
dUTPase activity and the absence of a significant stimula-
tion of host enzyme expression during infection of quiescent
cells (Gribaudo et al., 2003) may contribute to the increase
of intracellular dUTP levels. In turn, the subsequent cycles
of uracil misincorporation followed by excision promote the
transition to efficient late-phase DNA amplification. High
dUTP/dTTP ratios, therefore, may not be detrimental to
HCMV replication.
Because the UL72 ORF remained open in all the HCMV
strains (Fig. 4), it can be presumed to encode a functional
protein. However, its inactivation did not significantlyimpair in vitro HCMV replication in growing fibroblasts
because only a moderate defect was observed at the lowest
MOI. We characterized two independently isolated UL72
mutants by a strategy recently employed for the analysis of
other HCMV genes (Hahn et al., 2003; Wagner et al.,
2002). Plaque size and morphology of each mutant viruses
were comparable to those of AD169 under both optimal or
suboptimal conditions (such as growing or growth-arrested
cells). Insertional mutagenesis procedures may alter adja-
cent genes. Hence, we verified that insertion of the kanR
cassette into the UL72 ORF did not alter transcription of
neighboring UL71 and UL73 genes (data not shown). We
conclude that the 46-kDa protein product UL72 is nones-
sential for in vitro propagation of the virus. This finding is
consistent with the functional profilings of the whole
HCMV genomes (Dunn et al., 2003; Yu et al., 2003).
These functional maps were obtained by global mutational
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cultured fibroblasts. In both studies, UL72 was recognized
as nonessential for viral replication in fibroblasts and only
minor growth defects were observed with the mutant
viruses. It is likely, therefore, that UL72, like most HCMV
genes whose products have proved to be nonessential for
replication in fibroblasts, has evolved to gain a new
function presumably related to the virus growth in the
natural host, such as dissemination, growth in specific
target tissues and pathogenesis, or to counteract host
immune reactivity. Relevant to this is the finding that
mutations abolishing the glycosylase activity of vaccinia
virus UNG without affecting viral DNA replication in
cultured cells reduce the virulence of the catalytic-site
mutants in a mouse infection model (De Silva and Moss,
2003). However, speculation about the UL72 emergent
function cannot be solely based on extrapolation from aa
sequences because they did not reveal any significant
homology to proteins other than herpesvirus dUTPases.
Moreover, the large subunit of ribonucleotide reductase is
another example of a CMV-encoded protein presumed to be
involved in nucleic acid metabolism that has lost its original
activity. Both the human (UL45) and mouse (M45) genes,
in fact, encode enzymatically inactive homologs of the
large subunit. Furthermore, deletion of the UL45 gene from
both the AD169 genome and that of a clinical isolate did
not result in any significant growth defect because the
mutated viruses grew equally well in fibroblasts and endo-
thelial cells. These finding clearly indicate that UL45’s
functions are dispensable for HCMV growth in both cell
types (Hahn et al., 2002). By contrast, murine M45 has
been proved to be essential for MCMV growth in endo-
thelial cell cultures (Brune et al., 2001) and its deletion
impairs the in vivo replication of DM45 viruses, indicating
that the new function(s) gained by M45 are related to
dissemination or growth in the natural host (Lembo et al.,
2004). Therefore, it can be envisaged that the generation of
murine CMV mutant viruses deleted of the counterpart
M72 gene and evaluation of both their growth character-
istics in cultures and their ability to disseminate and
replicate in the natural host will provide further insights
into the 72 ORF’s functions.Materials and methods
Cells and culture conditions
Low-passage human embryonic lung fibroblasts (HELF
cells) were grown as monolayers in minimum essential
medium (MEM) (Gibco/BRL) supplemented with 10% fetal
bovine serum (Gibco/BRL), 2 mM glutamine, 1 mM sodi-
um pyruvate, 100 U/ml penicillin per ml, and 100 Ag/ml
streptomycin sulfate. Quiescent cells (arrested in G0/G1
phase) were obtained by culturing the subconfluent cultures
for 48 h in MEM supplemented with 0.5% serum (low-serum medium). Flow cytometry demonstrated that about
90% were growth-arrested.
Viruses
The HCMV strain AD169 was purchased from ATCC
(VR-538). Viral stocks were prepared by infecting human
embryonic fibroblasts at a virus-to-cell ratio of 0.01. Cells
were incubated in MEM supplemented with 1% heat-inac-
tivated fetal bovine serum and cultured until a marked
cytopathic effect was seen. Virus stocks were then pre-
pared from sonicated cells and centrifugal clarification
and frozen without further processing at 80 jC. Mock-
infecting fluid was prepared from uninfected cells by the
same procedure. Virus titers were determined by stan-
dard plaque assay on HELF cells. HCMV clinical isolates
(VR5438 and VR6264) (provided by Prof. G. Gerna,
University of Pavia, Italy) were propagated in HELF cells.
HCMV strain TB40/E (provided by Dr. C. Sinzger, Univer-
sity of Tu¨bingen, Germany) was propagated in human
umbilical vein endothelial cells (HUVEC) to preserve its
natural endothelial cytopathogenicity. RVAD169 reconsti-
tuted virus and RVAD169DUL72 (designated RVDUL72)
mutant viruses were propagated in HELF cells.
Construction of UL72 virus mutant by site-directed
mutagenesis
Oligonucleotides with 3V homology to sequences flank-
ing a kanR marker and 5V homology to sequences flanking
the viral region to be deleted (UL72) were used to PCR
amplify pACYC177 (New England Biolabs) DNA to gen-
erate a linear DNA fragment containing the kanR marker
tailed onto short regions of HCMV homology. The PCR
fragment was electroporated into cells that contained
AD169-BAC and transiently expressed the recombination
functions reda/h/g (Datsenko and Wanner, 2000; Hahn et
al., 2003; Muyrers et al., 2000; Wagner et al., 2002).
Colonies containing BACs with the kanR marker inserted
were selected on plates containing both kanamycin and
chloramphenicol.
The following primer pairs were used to generate the
linear PCR recombination fragment for AD169DUL72:
UL72-for: 5V-TTG GAA AAC GTA CGT GAT CAC
GGA CAC GAC GAG TAC GGG GTT TCT CAT
AGA CGT ACT TTA TTA GGC GAT TTA TTC AAC
AAAGCCACG-3V; UL72-rev: TCCGCATCGTCATCA
GGC TCC ATC ATC CTA GCC GAG AAA TCC GTC
AAC ATG CGT TAC TGC GTG CGT GCC AGT GTT
ACAACCAATTAACC-3V. HCMV-homologous sequences
on the 5V ends of the oligonucleotides are in boldface.
Nucleic acid analysis
Viral DNA and BAC DNA isolations were performed as
previously described (Hahn et al., 2002, 2003). HindIII- or
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0.5% agar gel, visualized by ethidium bromide, and blotted
onto nylon membranes. Hybridization conditions were as
previously described (Hahn et al., 2002, 2003). Southern
blots were probed with the kanamycin resistance gene
contained in the 1.3-kb BamHI–XhoI fragment form plas-
mid pACYC177, labeled with digoxigenin using the DIG
DNA labeling kit (Boehringer Mannheim) according to the
manufacturer’s instructions.
For UL72 gene sequence analysis, total DNAwas isolated
from HELF cells infected with the HCMV AD169, the
VR5438, or the VR6264 strains, and from HUVEC cells
infected with the TB40/E strain, by resuspending cell pellets
in lysis buffer (10 mM Tris–Cl, pH 8.0, 25 mM EDTA, 100
mM NaCl, 0.5% SDS, 100 Ag/ml proteinase K) and incubat-
ing the mixtures at 50 jC for 18 h. Digestion was followed by
phenol–chloroform extraction, ethanol precipitation, and
RNase treatment (1 Ag/ml of RNase A for 1 h at 37 jC).
The entire UL72 ORF from each HCMV strain was then
amplified by PCR, cloned into the pGEM-T-easy plasmid
(Promega), and subsequently sequenced by the dideoxy-
chain terminator method. Nucleotide sequences were ana-
lyzed using the Clustal X (1.8) multiple sequence alignment
program (European Bioinformatics Institute).
To evaluate RVAD169 and RVDUL72 DNA synthesis in
infected HELF cells, total DNAwas isolated at the indicated
times postinfection and its 2-fold dilutions were immobi-
lized on a hybridization membrane and sequentially hybrid-
ized with 32P-labeled probes prepared from the PstI–BamHI
DNA fragment of the HCMV IE1 gene (exon 4) and mouse
G3PDH cDNA. The membranes were autoradiographed and
the hybridization signals were quantified with the Bio-Rad
Image Analysis System.
For RNA analysis, at the indicated times, infected HELF
cells were rinsed twice with ice-cold phosphate-buffered
saline (PBS) and total cellular RNAwas isolated as described
(Ausubel et al., 1994). Total RNA (30 Ag) was fractionated on
a 1% agarose, 2.2 M formaldehyde gel, and then blotted onto
nitrocellulose membrane (Hybond C-extra, Amersham). The
filters were baked for 2 h at 80 jC and prehybridized for 6 h at
60 jC in 50% formamide, 6 SSC (1 SSC is 0.15 M NaCl,
0.015 M sodium citrate), 5Denhardt’s solution, 0.5% SDS,
100 Ag/ml denatured salmon sperm DNA. The hybridizations
were carried out at 60 jC overnight with 106 cpm/ml of
ssRNA radiolabeled probes corresponding to the 833-nt
HindIII–SmaI segment from the UL72 gene cloned in pBlue-
script SK plasmid (Stratagene). Antisense RNA transcripts
were generated by in vitro transcription with T3 RNA
polymerase (Ambion). Filters were washed twice for 30
min at 60 jC with 2 SSC, 0.1% SDS, and twice for 30
min at 60 jC with 0.1 SSC, 0.1% SDS.
Plasmids
pcDNA3-UL72 was constructed by inserting the UL72
ORF (1–388) between the BamHI and XhoI sites of thepcDNA3 plasmid (Invitrogen). The pGEX4T3-UL72 and
pGEX4T3-NdUTPase plasmids were constructed by insert-
ing between the BamHI and XhoI sites of pGEX4T3 the
PCR products corresponding, respectively, to the UL72
ORF (1–388) and the nuclear (N) isoform of the human
dUTPase (Ladner et al., 1996). pGEX4T3-UL72C was
generated by inserting the PCR product corresponding to
a UL72 segment comprised between positions 61 and 388
into the SmaI site of pGEX4T3.
Expression and purification of UL72 and NdUTPase
proteins
Synthesis of recombinant dUTPases and their purifica-
tion were performed according to Kremmer et al., 1999.
pGEX4T3-UL72 and pGEX4T3-NdUTPase proteins were
expressed in E. coli AD202. Flasks containing Luria–
Bertani (LB) broth were inoculated with 1/10 vol of an
overnight culture and incubated in a rotatory shaker at 37 jC
until the adsorbance at 600 nm reached 0.7. Then, IPTG
(Sigma) was added to a final concentration of 1 mM and
incubation was continued for 2 h at 37 jC. Cells were
collected by centrifugation for 15 min at 6000 rpm, washed
once in PBS, and resuspended in lysis buffer [150 mM
NaCl, 100 mM Tris–HCl, pH 8.0, 1 mM EDTA, 1 mM
DTT, 10% glycerol, 1% Triton-X, protease inhibitor cocktail
(Sigma), lysozyme 1 mg/ml]. Cells were then sonicated on
ice and the suspension was cleared by centrifugation for 20
min at 10000 rpm. The recombinant proteins, soluble under
these conditions, were analyzed by SDS-PAGE and visual-
ized by Coomassie Blue staining. The UL72 and NdUTPase
proteins were then affinity-purified on glutathione-sephar-
ose 4B (Pharmacia) beads as described (Ausubel et al.,
1994) and further purified by enzymatic release from the
GST moiety by digestion with thrombin) (Pharmacia). The
released proteins were dialyzed against 50 mM Tris–Cl, pH
7.5, 2 mM DTT, 10 mM MgCl2, 20% glycerol, and stored at
80 jC until use.
To generate an anti-UL72 serum, GST-UL72C (61–
388) was expressed in E. coli AD202 and affinity-
purified on glutathione-sepharose 4B beads (Pharmacia)
as described (Ausubel et al., 1994). The C-terminal part
of the UL72 protein was used for rabbit immunization to
produce antibodies against pUL72. The serum obtained
by bleeding at 1 week after the fourth immunization was
precipitated with ammonium sulphate at 45% of satura-
tion and IgG were then purified on a protein A affinity
column (Pharmacia) according to the manufacturer’s
specifications.
Enzyme assay
dUTPase activity was measured by evaluating the
hydrolysis of dUTP to dUMP. The 20-Al reaction mixture
contained 50 mM Tris–HCl, pH 7.5, 2 mM DTT, 10 mM
MgCl2, 1mg/ml BSA, 25 mM NaF, 2 mM PNPP, 1
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fied recombinant proteins (100 ng to 2 Ag). All the assays
in duplicate were incubated for 30 min at 37 jC and
reactions were stopped by boiling for 3 min. An aliquot of
the reaction mixture (2 Al) was loaded on a TLC PEI-
cellulose plate together with 2 Al of a solution containing
dUTP and dUMP (each at 100 mM) to provide an optical
marker under UV irradiation. PEI-cellulose plates were
then developed in 0.5 M LiCl and 2 M acetic acid and,
dried and examined under UV light. The marker spots
corresponding to dUTP and dUMP were then cut out and
the radioactivity associated was quantified by liquid scin-
tillation counting.
Immunofluorescence microscopy
HELF cells grown on coverslips were transiently trans-
fected with the pcDNA3-UL72 vector using the Lipofect-
amine plus reagent (Invitrogen) or infected with HCMV
AD169 (MOI of 0.2 PFU/cell). At 24, 48, 72, 96 h p.i.,
or 24 h post transfection, cells were washed with PBS,
fixed with cold acetone and methanol for 5 min at 20
jC and then washed again with PBS. Fixed cells were
permeabilized with 0.2% Triton X-100 in PBS for 20 min
at 4 jC, washed with PBS, and then incubated at RT for
1 h with normal human serum to block HCMV-induced
Fc receptors. Thereafter, infected cells were incubated
with the rabbit anti-UL72 antibody (diluted 100-fold)
and mouse anti-HCMV IEA mAb (clone E13, Argene
Biosoft) (diluted 100-fold) in PBS containing 10% of
normal human serum for 1 h at RT, while coverslips of
transfected cells were incubated only with the rabbit anti-
UL72 antibody (diluted 100-fold). After washing with
PBS–1% BSA, 0.05% Tween 20, coverslips of infected
cells were incubated with FITC-conjugated anti-rabbit Ig
(Sigma) and Texas Red-conjugated goat anti-mouse Ig
(Molecular Probes, Eugene, OR) antibodies in PBS–1%
BSA for 1 h at RT, while coverslips of transfected cells
were incubated with the FITC-conjugated anti-rabbit Ig
only and then stained with propidium iodide (0.1 Ag/ml).
Finally, coverslips were washed with PBS and mounted in
90% glycerol. Immunofluorescence microscopy was per-
formed on an Olympus IX70 inverted confocal laser
scanning microscope, equipped with a krypton–argon
ion laser (488/568). Images derived from both channels
(fluorescein and Texas Red) were simultaneously recorded
at identical apertures. The fluoroscein-derived images
were assessed as green and the Texas Red-derived images
as red.
Preparation of protein extracts and immunoblotting
Whole-cell extracts were prepared by resuspending pel-
leted cells in lysis buffer containing 125 mM Tris–Cl, pH
6.8, 1% SDS, 20 mM dithiotreitol, 1 mM phenylmethylsul-
phonyl fluoride, 4 Ag/ml leupeptin, 4 Ag/ml aprotinin, 1 Ag/ml pepstatin. After a brief sonication, soluble proteins were
collected by centrifugation at 15000  g. Supernatants were
analyzed for protein concentration with a Bio-Rad Dc
protein assay kit (Bio Rad Laboratories) and stored at
80 jC in 10% glycerol. Proteins were separated by
SDS-PAGE and then transferred to Immobilon-P mem-
branes (Millipore). Filters were blocked in 5% nonfat dry
milk in 10 mM Tris–Cl, pH 7.5, 100 mM NaCl, 0.1%
Tween 20, and immunostained with the rabbit anti-UL72
antibody (diluted 1000-fold), the mouse anti-HCMV IEA
mAb (clone E13, Argene Biosoft) (diluted 200-fold), or the
mouse anti-HCMV UL44 mAb (purchased as antibody
1202 from Goodwin Institute, Plantation, Fl) (1:1000), the
mouse anti-HCMV UL99 mAb (purchased as antibody
1207 from Goodwin Institute, Plantation) (1:1000), or the
mouse anti-actin mAb (Chemicon International) (diluted
2000-fold) at RT for 1 h. Immune complexes were detected
with either sheep anti-mouse Ig or goat anti-rabbit Ig anti-
bodies conjugated to horseradish peroxidase (Amersham)
and visualized by enhanced chemiluminescence (Super
Signal, Pierce).
Analysis of mutant virus growth and DNA synthesis
To determine the extent of viral replication, multiple-step
growth analyses were performed in HELF cells incubated in
low-serum medium for 48 h (quiescent cells) or plated the
day before the infection (growing cells) and then infected
with RVAD169 or RVDUL72 (clones 2 and 3) (MOI of 1 or
0.1 PFU/cell). One well per plate was mock-infected and
served as cell control. Virus absorption medium was then
replaced with the same low-serum medium or with fresh
growth medium. At the indicated time postinfection, cells
and supernatants were harvested and disrupted by sonica-
tion. The disrupted cells were centrifuged at 500  g for 10
min, and supernatants were assayed for infectivity by a
standard plaque assay.
To evaluate RVAD169 or RVDUL72 DNA synthesis,
HELF cells were grown to subconfluence in 24-well plates,
incubated in low-serum medium for 48 h (quiescent cells),
or plated the day before infection (growing cells) and then
infected with RVAD169 or RVDUL72 (MOI of 0.1 PFU/
cell). One well per plate was mock-infected and served as
cell control. Total DNA was then isolated at the indicated
times postinfection as described above.Acknowledgments
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